Nov 30, 2022 / 01:00PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Good morning, everyone. Thanks for joining us on Day 2 of HealCoNext. Pleasure to have Boston Scientific kick off day 2 for us. We have Jeff Mirviss, President of PI. That's Peripheral Interventions. We also have Cat Jennings, President of Peripheral Vascular and from Investor Relations, we have Lauren Tengler.
Before we start, I have to say we're used to asking, what is the utilization big picture? How is acute trending? And when we get down to segment level, sometimes I have to do some work. So I learned a lot about PI, preparing this Q&A list. So thanks for taking the time this morning, Jeff and Cat.
Jeffrey B. Mirviss - Boston Scientific Corporation - Executive VP & President of Peripheral Interventions
Pleasure to be here.
Boston Scientific Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 30, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers